GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Future Policy Benefits

Abbott Laboratories (Pakistan) (KAR:ABOT) Future Policy Benefits


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.